Loading
Steven Rosen is a lymphoma specialist who directs City of Hope's research enterprise.
Steven Rosen is Provost and Chief Scientific Officer of City of Hope and Director of its Beckman Research Institute, having previously directed Northwestern's Lurie Cancer Center for 25 years. A haematologist-oncologist specialising in lymphoma and translational science, he leads Beckman Research Institute and City of Hope's comprehensive cancer centre designation. His papers include a Blood Reviews article on primary cutaneous lymphomas and their treatment options and a Blood phase II trial of 2-chlorodeoxyadenosine for cutaneous T-cell lymphoma. His work links lymphoma research, including diffuse large B-cell lymphoma, to cancer research leadership.
| Title | Journal | Year |
|---|---|---|
| Primary cutaneous lymphomas: a review with current treatment options | Blood Reviews | 2003 |
| Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma | Blood | 1996 |